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英文缩写        英文全称                      中文全称 
PRP      Platelet-rich Plasma                     富血小板血浆 
VEGF    vascular endothelial growth factor      血管内皮生长因子 
aFGF     acid fibroblast growth factor    酸性成纤维细胞生长因子 
bFGF     basic fibroblastgrowth factor    碱性成纤维细胞生长因子 
PDGF     platelet-derived growth factor          血小板源生长因子 
TGF      transforming growth factor               转化生长因子 
EDTA     Ethylene diaminetetraacetic acid           乙二胺四乙酸 
EGF      epidermal growth factor                  表皮生长因子 
IGF      insulin-like growth factor              类胰岛素生长因子 
HE       Hematoxylin and eosin                     苏木精伊红 
PBS      Phosphate buffered saline                 磷酸盐缓冲液 
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选健康新西兰大白兔 15 只，体重 2.0~2.5kg，雌雄不限，由厦门大学附属东
南医院动物实验中心提供并寄养，正常饮食。自兔耳中央动脉抽取全血 12mL，
经过“二次离心法”，获得 PRP 约 1.2ml，再将 PRP 和 10%无菌 CaCl2 溶液以 3：
1 混合，制备成活化的 PRP。本实验采用自身配对设计，随机选择一侧为 PRP
侧，另一侧为空白对照侧，实验分为 3 天组、7 天组和 14 天组，每组 5 只大白
兔。于背部与脊柱对称的左右两侧作 8cm×2cm、蒂部位于双侧髂棘连线上的全
层皮瓣，各组分别给予下述处理：①空白对照侧：不行任何处理，皮瓣原位缝合。
②PRP 侧：在皮瓣基底面均 涂抹 PRP，约 0.1ml/cm2，用强生“5-0”丝线间断
原位缝合皮瓣。通过观测各组大体观察、皮瓣成活率、组织学观察及血管密度测






















摘  要 
III 
的延长，实验侧和对照侧的皮瓣成活率无明显差异。 




4．免疫组化测定血管内皮生长因子(vascular endothelial growth factor, VEGF)和





的 PRP 局部应用于皮瓣基底面，另一侧为对照侧，分别观察 3 天、7 天和 14
天，结果显示实验侧的皮瓣存活率较对照侧高。 
 



















In the study,we adopt the "twice centrifugation" to extract platelet-rich plasma
（Platelet-rich Plasma，PRP）from animal itself.Product two random skin flaps on the 
back of the ranbbit with spinal symmetrical, aspect ratio as 4:1,and wendy department 
located in iliac ridge line. Apply the preparated PRP in the one side flap.Explore the 
influence of flap survive by locally using PRP.Deeply understand the role of 
platelet-rich plasma (PRP) from their own body in the process of flap transfer, and  
further study the action principle of PRP promoting skin flap growth , providing 
theoretical basis for the clinical application of PRP . 
Content： 
Choose 15 health New Zealand big white rabbits,Weight 2.0 ~ 2.5 kg,any male or 
female,which are provided and fostered by xiamen university affiliated southeast 
hospital animal experiment center,normal diet.Extract 12ml of the whole blood from 
the central artery of rabbit ears.After "the second centrifugation,"Get PRP about 1.2 
ml.We used own pairing design in this experiment,selected randomly one side as  
PRP side,another side as blank control side.They are divided into 3 days' groups, 7 
days' groups and 14 days' groups, and 5 rabbits in every group. On the both sides of 
spinal column,we made two whole storey flaps about 8 cm x 2 cm, with wendy 
department located in bilateral iliac ridge line. Each group were given the following 
treatment separately:Blank control side:No any treatment, sutured flap in situ ;PRP  
side:daubed PRP in the inner of skin flap ， about0.1ml/cm2, sutured flap 
discontinuously with 5-0 silk in situ.Observed every group about general observation, 
the flap survival rate, histologic observation and vascular density measuring, 
immunohistochemical determinated VEGF and CD34,then compared with the 
contralateral side, the difference of flap survival situation that Whether there is 
statistical significance in each time group, and discussed its survival mechanism. 
Results： 
1.General observation:Macroscopic observation showed survived flap was soft, ruddy, 
bleeded when acupunctureed;The necrosis flap is hard, black, acupuncture with no 
bleeding.In each time group, the area of necrosis skin flap of the experimental group 















of flaps,and the vessels of flap PRP side in 14 days group dilated obviously,while it 
did not change significantly in blank control side. 
2.The detection of flap survival rate:In each time group ,the flap survival rate in the 
PRP side is larger than that in blank control side,but with the extension of time, the 
differences between the experimental side and the contrast side are not notable. 
3.Histological observation and vascular density detection:With the extension of time , 
the inflammation is getting lighter, density of blood vessels are increasing, the 
inflammation in 14 days group is the lightest, blood vessels' density is the largest, and 
the experimental side's inflammatory response is lighter than that in control side, 
experimental side's vascular density is larger than that of  control side in the far end 
flap and the flap's organization HE dyeing each time flap. 
4.Immunohistochemical determination of vascular endothelial growth factor (VEGF) 
and CD34:Use corresponding antibody mark VEGF respectively and CD34,positive 
performance can be seen in endothelial cells , and it is higher in experimental side 
than that in blank control side. 
Conclusion： 
Make two symmetrical random flaps on the back of New Zealand big white rabbit as 
animal experiment model, one side for experimental side. Apply the preparated PRP  
in the basement of flaps locally. the orther side as control side, then observe 3 days, 7 
days and 14 days separately.With the extension of time, the flap survival rate in the 
experimental sides is higher than that in control sides. 
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第一章  绪  论 
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(acid fibroblast growth factor，aFGF) 和碱性成纤维细胞生长因子(basic fibroblast 






















第一章  绪  论 
2 
放。于是，学者们便联想到了早在 1977 年就通过全血首次分离制备的富血小板






growth factor, PDGF)、转化生长因子-β1 和 β2( transforming growth factor-β1、β2, 
TGF-β1、β2)、血管内皮生长因子(vascular endothelial growth factor, VEGF)、血小
板衍生内皮细胞生长因子、白介素-1（IL-1）、表皮生长因子(epidermal growth factor, 
EGF)、成纤维细胞生长因子、血小板激活因子和类胰岛素生长因子( insulin-like 
growth factor,IGF)等【3-7】，这些生长因子已被证实在单独应用或联合应用时能刺激
细胞增殖分化【8】，促进软组织的修复【9-10】。PRP 中高浓度的 PDGF、EGF 和 VEGF
可以促进血管再生，重建局部血供。于是，我们可以设想是否可以将 PRP 应用
于移植皮瓣，促进皮瓣血管生成，从而提高皮瓣存活率。 








利于促进骨再生和组织愈合，使 PRP 在口腔科和骨科成为研究的热点。PRP 在
牙科骨缺损的应用中，不仅能与自体移植骨或者脱细胞骨基质联合应用促进骨再
生，而且能促进牙周组织的生长【12】。在骨科的实验研究中，将 PRP 与凝血酶和




























制备成活化的 PRP 备用。在新西兰大白兔背部与脊柱对称的左右两侧作 8cm×
2cm、蒂部位于双侧髂棘连线上的全层皮瓣，皮瓣形成后每只动物随机选择一侧
为实验侧，在皮瓣基底面均 涂抹制备好的自身 PRP 后进行原位缝合；另一侧
作为对照侧，不行任何处理，直接进行皮瓣原位缝合。分成三组观察，分别观察
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